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1. INTRODUCTION  
The development of oral controlled-release drug 
delivery systems is driven by clinical outcome 
benefits, aiming to improve the efficacy and the 
quality of drug administration. Ideally, the well-
developed system should be able to control the release 
characteristics or in some instances, be able to target a 
drug directly to a specific absorption site. Accordingly, 
one or more of the following benefits can be achieved: 
the maintenance of the effective therapeutic drug level 
for the desired period of time, the reduction of 
frequency of dosing and/or dose required, the 
minimization of the incidence of side effects or 
toxicity, resulted from the fluctuation of drug 
concentration in circulation, and the improvement of 
patient compliance.
1,2
 Different types of controlled-
release drug delivery systems are defined based on the 
compositions and/or the mechanism of controlling the 
drug release such as matrix-type, reservoir-type and 
solvent activated-controlled type
2
. Among these, a 
matrix-type drug delivery system has been received 
more interest due to its simplicity and economy, ease 
to fabricate, high flexibility to modulate the drug 
release profiles and more feasibility to 
manufacturability. Waxy substances have been widely 
used as a matrix forming agent for controlled-drug 
release systems and are still attractive at present
3-6
. 
Most of the waxy carriers are inert and considered as 
GRAS ingredients. They are for examples, carnauba 
wax, beeswax, cetyl alcohol, stearyl alcohol, glyceryl 
monostearate and hydrogenated oils. The release of 
drug from wax matrix is controlled by a combination 
of several processes including surface erosion, 
permeation of water through matrix and diffusion of 
drug through pores which generally occurs after the 
drug has dissolved in the penetrating water
5
. However, 
due to its high hydrophobicity, penetration of water 
into the dense wax matrix is quite limited. The desired 
characteristics of drug release can be manipulated by 
incorporating some additives into the wax. These 
agents are known as release-controlling agents or more 
specifically as channeling agents or wicking agent, 
depending on their mechanisms of action for 
enhancing the drug release. Substances employed as 
release-controlling agents are mannitol, PEG 4000, 
PEG 6000, PVP k30, sodium chloride, 
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The wax matrix controlled-release systems can be 





 and melt 
granulation
15-17
. Among these, the melt granulation 
technique has been used extensively because it is a 
solvent-free method and no sophisticate equipment is 
needed to prepare the system. 
 





      
                (1)
  
where Q is the amount of drug released per unit 
surface area at time t, D is the drug diffusion 
coefficient in the matrix phase, Cs is the drug solubility 
in the dissolution medium, A represents the drug 
concentration in the matrix,  is the porosity and  
denotes the tortuosity of the matrix, whereas k is the 
release rate constant.  
According to equation (1), when the drug is highly 
soluble in water, i.e., Cs A, the cumulative amount 
of drug released is a linear function of the square root 
of time which can be simply illustrated in equation (2): 
 
       
         (2) 
Where, Mt/M denotes the drug fraction released at 
time, t  
The objective of this study was to gain an insight into 
the mechanism of the release controlling agents by 
investigating the effect of two different channeling 
agents, potato starch (PS) and icing sugar (IS) on the 
release of chlorpheniramine maleate (CPM), the model 
drug from carnauba wax (CW) matrix tablets.  
2. MATERIALS AND METHODS 
Chlorpheniramine maleate, USP used in this study was 
from T.O. Chemicals, Co. Ltd., Carnauba wax, potato 
starch and icing sugar were of USP grade. 
2.1 Preparation of wax matrix 
The CPM-carnauba wax matrices with or without 
channeling agents were prepared by melt granulation 
method. Briefly, the drug and the channeling agents 
(PS or IS) were separately ground and passed through 
200/325 mesh sieve prior to use. According to 
specified formula (Table 1), the calculated amount of 
the drug, PS or IS was added to the molten wax. The 
mixture was continuously stirred until congealed. The 
hard mass was then pulverized and passed through 
60/70 mesh sieve (approx. 210-250 m).     
 
Table 1 Composition (%w/w) of wax and channeling agents in each formulation of wax matrix 










F1 4.0 96.0 - - 1:0 0 
F2 4.0 48.0 48.0  1:1 50.0 
F2 4.0 32.0 64.0  1:2 67.0 
F4 4.0 64.0 32.0  2:1 33.0 
F5 4.0 48.0 - 48.0 1:1 50.0 
F6 4.0 32.0 - 64.0 1:2 67.0 
F7 4.0 64.0 - 32.0 2:1 33.0 
** calculated as CW weight basis 
 
2.2 Preparation of wax matrix tablets  
The wax matrix powder was compressed into tablets 
using Hydraulic press, with a ¼” flat faced punch and 
dies set. A 300-mg matrix powder portion was filled 
into the die without any lubricant. The compression 
force was 20 kN with contact time of 30 seconds.  
2.3 Physical characterization of wax matrix tablets 
The diameter and the thickness of the wax matrix 
tablets were measured using a Vernier Caliper 
(Mitutoyo, Japan). The hardness and weight of the 
tablets were determined using ERWEKA TBT 28 
apparatus (Erweka GmbH, Germany) and an electronic 
balance (Ohaus TS120S), respectively. 
2.4 In vitro release study 
The release of CPM from the matrix tablets was 
determined using the USP apparatus II, paddle method 
(Dissolution Tester, SR2 Hanson Research Co., Ltd. 
CA, USA). The dissolution medium was 500 ml of de-
aerated distilled water maintained at 370.5 C. The 
rotation speed of the paddle was kept constant at 100 
rpm. The sample solution was withdrawn from vessels 
at various time intervals up to 8 hours. An equal 
volume of fresh dissolution medium maintained at the 
same temperature was immediately replaced at each 
sampling time. After appropriate dilution, when 
necessary, the sample solution was analyzed for the 
drug content by UV spectrophotometer (Spekol
®
 1200, 
Analytik Jena, Germany). All dissolution tests were 
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2.5 Water uptake and erosion determination  
The water uptake by the wax matrix tablets was carried 
out according to those previously described 
19
 with 
partial modification. The study was performed using 
the same procedure of the release study. At the end of 
the first and the forth hour of the test, the tablets were 
taken from the vessel, removed excess water by 
blotting with tissue paper, weighed and then dried at 60 
C to constant weight. The percentage of water uptake 
and the percentage of matrix erosion were obtained by 
the following equations: 
Water uptake (%) = (wet weight − dry weight) × 100 
      dry weight  
Erosion (mass loss) (%) = [(Wi − Wf)/Wi]×100 
Where,   Wf= remaining (dry) weight 
Wi=original weight 
2.6 Microscopic and scanning electron microscopic 
investigation 
The internal structures of the matrix tablets before and 
during the dissolution process were photographed 
using scanning electron microscope under electron 
radiation of 15kV (JSM- 5910LV, Jeol, Japan). 
2.7 Analysis of the release data 
The mean percentage of drug released from wax matrix 
tablets at any time intervals were fit against time 
according to Korsmeyer-Peppas and Higuchi diffusion 
models.  K values were obtained from the slope of the 
linear relationships.  
2.8. Statistical analysis 
Descriptive statistics was used to summarize matrix 
tablets characteristics, i.e. weight, hardness, diameter 
and thickness. The statistical difference between matrix 
tablets characteristics and k values obtained from 
various formulations were tested using one-way 
ANOVA at a significant level of 0.05.  
3. RESULTS AND DISCUSSION 
3.1 Preparation of wax matrix  
The melt granulation method was selected to prepare 
CPM-wax matrix. Potato starch and icing sugar were 
representative candidates of water-insoluble and water-
soluble channeling agents, respectively. As CPM, 
potato starch and icing sugar were not soluble, but 
thoroughly dispersed in wax matrix; the particle size of 
each ingredient was controlled to minimize its effect on 
the drug release. The molten mixture was continuously 
agitated until solidified in order to ensure the 
homogeneity of the resultant matrix. The solidified 
matrix was pulverized and passed through an optimal 
sieve mesh to obtain the uniform particle size. 
3.2 Physical characterization of wax matrix tablets 
Table 2 summarized the characteristics of the wax 
matrix tablets, including weight, hardness, diameter 
and thickness. There was no statistically significant 
difference (p < 0.05) for all tablet characteristics 
between formulations, except tablet diameters and 
thickness.  It was noticed that the tablets with higher 
wax content exhibited higher thickness values due to 
low density of the wax. Although specific surface area 
of the tablet is directly proportional thickness, this 
appeared to have negligible effect when compared to 
the pronounced effect of channeling agents as will be 
demonstrated in the following topic. 
 
Table 2 Matrix tablets characteristics 
Formulation Weight  SD*  
(g) 
Hardness  SD 
 (N) 
Diameter  SD (mm) Thickness  SD 
(mm) 
CW 0.297  0.001  13.7 10.008 0.001 3.870 0.002 
CW:PS 1:1 0.299  0.001 13.4  0.02 10.030 0.001 3.231 0.001 
CW:PS 1:2 0.299  0.001 13.2  0.03 10.039 0.001 3.025 0.001 
CW:PS 2:1 0.299  0.001  13.7  0. 02 10.012 0.001 3.471 0.001 
CW:IS 1:1 0.298  0.001  13.7 10.018 0.001 3.174 0.001 
CW:IS 1:2 0.299  0.002 13.6  0.01 10.034 0.001 2.929 0.001 
CW:IS 2:1 0.299  0.001  13.7 10.024 0.001 3.438 0.001 
(Mean  standard deviation, * n=20; n=10) 
 
3.3 In vitro release study 
The profiles of drug release from wax matrix tablets 
containing PS and IS were illustrated in Figure 1 and 
Figure 2, respectively. It was shown that the drug 
release increased with the increasing amount of PS or 
IS. The extent of drug release was also affected by the 
types of channeling agents. PS could effectively 
enhance the drug release at 33 %w/w and 50 %w/w 
(CW: PS 1:2 and CW: PS 1:1) and further increase of 
the drug release was obviously observed at 67 %w/w. 
The drug release from matrix tablets containing IS at 
low concentration of 33 %w/w was comparable to that 
of the neat wax matrix. However, IS produced the 
significant increase in drug release at 50% w/w and 
above.  
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To gain more insight into the mechanism of drug 
release, the CPM release data were fitted in 
Korsmeyer-Peppas model, a simple relationship that 
describes a fraction of drug release versus time 
according to the following equation. 









 is a fraction of drug release at time t 
k is a release rate constant 
n is a release rate exponent 
 
Figure 2 Release profiles of CPM from wax matrix tablets; using IS as a 
















Figure 1: Release profiles of CPM from wax matrix tablets; using PS  as a 
channeling agent  CW;    CW: PS 1:1,  CW: PS 1:2,   CW: PS 2:1  
Time (min.) 
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The value of n describes the release mechanism of 
drug release from the matrix. It was found that the n 
values obtained from the release profiles of all matrix 
tablets in this study were close to 0.50, indicating that 
they followed Higuchi model. The results agreed with 
the studies previously reported 
8, 15, 20-21
. The curve 
fittings for Higuchi model of the drug release from the 
matrix tablets containing PS and IS were illustrated in 
Figure 3 and Figure 4, respectively. The release rate 
constant, k values, as well as r
2
 obtained from the 
curve fitting were summarized in Table 3. It can be 
observed that the k values significantly increased with 
the increasing amount of PS or IS in the matrix 
tablets. This finding was in agreement with those 
previously reported; the incorporation of hydrophilic 
















Figure 5 illustrated the internal structures of the matrix 
tablets by SEM micrographs, at initial and after one 
and four hours of the drug release study. In case of PS, 
small cracks or channels were observed in matrix 
tablets after exposed to the release medium as clearly 
demonstrated in Figure 5(b). This was attributed to the 
swelling property of potato starch on contact with 
penetrating water. The swelling force was sufficiently 
strong to produce small cracks or channels, thus 
resulting in an increase of matrix porosity and 
consequently enhanced the rate of drug release 
22
. The 
penetration of water into wax matrix progressed with 
time and cracks and channels were formed deeper 
inside the matrix tablets as shown in Figure 5(c). The 
appearance of the internal structure conformed very 
well with the release study results. Accordingly, 
swelling of PS was proved to be the major mechanism 





F1, CW 1.345  0.070 0.975 
F2, CW:PS 1:1 1.868  0.030 0.989 
F3, CW:PS 1:2 2.413  0.029 0.969 
F3, CW:PS 2:1 1.514  0.032 0.982 
F2, CW:IS 1:1 1.859  0.037 0.981 
F3, CW:IS 1:2 3.048  0.049 0.970 
F3, CW:IS 2:1 0.942  0.076 0.985 
Figure 4 Higuchi’s Plots of CPM from wax matrix 
tablets; using IS as channeling agent  CW;   
CW: IS 1:1,  CW: IS 1:2,   CW: IS 2:1 
Figure 3 Higuchi’s Plots of CPM from wax matrix 
tablets; using PS as channeling agent  CW;   CW: 
PS 1:1,  CW: PS 1:2,   CW: PS 2:1 
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Figure 5- Internal structure of CPM matrix tablets containing PS (left) and IS (right) 1:1 
(a) initial and after dissolution;  (b) 1 hour and  (c) 4 hours under SEM analysis (x 150 and x 300 magnification) 
 
The internal structures of the matrix tablets containing 
IS as a channeling agent from the drug release study by 
SEM micrograph were also shown in Figure 5. IS 
dissolves readily in water upon exposure to penetrating 
water. As a result, a great number of small holes were 
subsequently produced after IS dissolved and left from 
the matrix tablet. The formation of holes inside the 
tablets increased the release surface for the drug and 
also accelerated the rate of water penetration into the 
matrix tablet. These could enhance the drug release 
from inert wax matrix. At low concentration of IS, a 
limited numbers of small holes was created and they 
were rarely connected, the release of drug thus could 
be enhanced to some extent due to the increase in 
matrix porosity. As the concentration of IS increased, 
the number of these small holes increased (Figure not 
shown).  At longer time, not only the number and the 
size of holes increased, a large channel were also built 
up resulting from interconnection of these holes as 
shown in Figure 5(c). From such loosed matrix 
structure, the release of drug was thus dramatically 
increased.  
3.4 Water uptake and erosion determination 
Figure 6 showed the effect of PS and IS on the 
percentage of water uptake and the percentage of tablet 
erosion at the end of 4 hours of the release study.  It 
was shown that the channeling agent, either water-
insoluble or water-soluble type increased water uptake 
and tablet erosion of wax matrix tablets, however, at 
different extents. The values were not significantly 
different in tablets containing 33 %w/w for each 
channeling agent (wax: PS/IS 1: 2 by weight). 
However, both values markedly increased at PS or IS 
concentrations of 50% w/w and above. It was of 
interest that, at certain concentration above 50 %w/w, 
PS exhibited higher water uptake than IS as showed in 
Figure 6 (a), whereas IS exhibited higher erosion at the 
comparable concentration. This attributed to the 
different property of channeling agent on controlling 
the drug release. PS had strong water attraction, then 
swelled and created cracks thereafter, whereas IS, 
readily dissolves then leached out from the matrix. On 
comparison, the phenomenon produced by IS induced 
more tablet erosion than PS did. The changes in tablet 
internal structure were evidenced by SEM micrographs 
in Figure 5. 
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The relationship between the rate constant of drug 
release and the percentage of channeling agents was 
showed in Figure 7. The linear relationship was 
observed for PS containing matrix tablets, implying 
that the cracks or capillaries that promoted the drug 
release were generated dependently on the 
concentration of PS.  
 
 
In case of IS containing matrix tablets, the biphasic 
curve was obtained. At low concentration of IS, the 
release of drug occurred with almost the constant rate, 
and it abruptly increased following the concentration 
when the percentage of IS reached approximately 40% 
and above. This was clearly demonstrated by SEM 
micrographs of matrix tablet containing IS of 50% 
which showed a network of interconnected holes after 
the release study at 4 hours in Figure 5(C) and clearly 
demonstrated by the high percentage of tablet erosion. 
Understanding of the difference between the 
mechanisms of PS and IS on promoting the drug 
release as aforementioned is very important. It 
provides a great help for a formulator to achieve the 
wax matrix formulation with the desired release rate of 
the drug without wasting much time. 
4. CONCLUSIONS 
The roles and the mechanisms of water-insoluble and 
water-soluble channeling agents, i.e., potato starch and 
icing sugar respectively on the release of 
chlorpheniramine maleate, water-soluble drug from 
carnauba wax matrix tablets were clearly 
demonstrated. The kinetics of the drug release from 
wax matrix fit well with Higuchi’s diffusion model. 
The incorporation of the two additives did not alter the 
kinetics of drug release. The rate of drug release 
significantly increased with the increasing amount of 
potato starch or icing sugar. However, the extent of 
drug release and the drug release profiles were directly 
affected by their properties. SEM micrographs were 
good visible evidences to provide insight how these 
additives work on enhancing the drug release. The 
results of this study could be helpful to give an idea for 
selecting suitable released-controlling agent in 
hydrophobic modified release formulation. 
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Figure 6 Relationships between percent of release-controlling agents and % water uptake (a),  and % erosion (b) 
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Figure 7 Relationship between the release rate constant, k 
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